Enter your login e-mail to the account
Search
Search parameters
Search results
- Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- Bipolar affective disorder in a female patient with breast cancer as a complication of anticancer therapy
doc. MUDr. Ladislav Slováček, Ph.D., MUDr. Birgita Slováčková, Ph.D.
(3/2013, Original articles & case reports )
- Neurologické komplikace protinádorové léčby
MUDr. Olga Zapletalová
(5/2003, Main topic )
- ACCES TO INNOVATIVE DRUGS IN ONCOLOGY IN SLOVAKIA – COMPARISON WITH THE WORLD
PharmDr. Dominik Tomek, MPH
(1/2008, Review articles ) - PHARMACOECONOMICS – ITS POSITION IN DRUG POLICY
prof. RNDr. Viliam Foltán, CSc., Mgr. Veronika Dubajová, PharmDr. Tomáš Tesař, PHD, MBA
(1/2008, Review articles ) - PHARMACOECONOMICS OF ONCOLOGIC TREATMENT FORM THE POINT OF VIEW OF HEALTH INSURANCE COMPANY
MUDr. Alexander Paluch, MUDr. Lucia Vitárius, MPH
(1/2008, Review articles ) - Správa zo 17. celoštátnej pracovnej konferencie SEKCAMA konanej v dňoch 17. a 18. mája 2012
doc. MUDr. Vladimír Bella, PhD.
(4/2012, Events ) - Milí čitatelia! - úvodné slovo
prof. MUDr. Stanislav Špánik, CSc.
(1/2011, Editorial ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(1/2008, Review articles ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - XI. KOŠICKÉ CHEMOTERAPEUTICKÉ DNI
MUDr. Michal Mego, PhD.
(1/2008, Events ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Pediatric oncology on the verge of 21. century: perspectives, aims and future visions
as. MUDr. Viera Bajčiová, CSc.
(1/2007, Review articles ) - SPRÁVA Z 30. SAN ANTONIO BREAST CANCER SYMPOSIUM, 13. – 16. DECEMBER 2007
MUDr. Vladimír Malec
(1/2008, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - ESMO BREAST CANCER COURSE: prvýkrát na Slovensku
doc. MUDr. Mária Wagnerová, CSc.
(1/2006, Events ) - Správa z X. Košických chemoterapeutických dní, 23. – 24. november 2006
MUDr. Radovan Barilla
(1/2007, Events ) - Current options in the treatment of HER2 low metastatic breast cancer
MUDr. Radovan Barila, PhD.
(2/2024, Review articles ) - Správa z konferencie Aktuálne problémy v manažmente gastrointestinálnych malignít
MUDr. Tomáš Šálek, MUDr. Peter Pichňa, CSc.
(1/2011, Events ) - CURRENT ALTERNATIVES FOR SECOND LINE CHEMOTHERAPY OF RECURRENT CIS-PLATIN REFRACTORY EPITHELIAL OVARIAN CANCER
MUDr. Radovan Barilla
(2/2006, Review articles ) - Publikujeme v zahraničí
(1/2011, Information & comments ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Late effects of anticancer therapy
MUDr. Mária Rečková, Prof. MUDr. Beata Mladosievičová, CSc.
(3/2015, Main topic ) - Diskusné fórum onkológov
(1/2009, Discussion forum ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Patient registries – a need for real data in the context of efficacy, safety and cost effectiveness
PharmDr. Dominik Tomek, MPH, RNDr. Mária Pšenková, Ing. Branislav Balvan
(2/2010, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - New trends in the immunotherapy of cancer
MUDr. Ján Lakota, CSc.
(6/2016, Review articles ) - Cancer drug consumption 2012-2015
Ing. Tomáš Mesároš, MBA, JUDr. Ing. Štefan Mesároš, PhD.
(2/2017, Main topic ) - Breast calcifications
MUDr. Silvia Šulajová
(1/2013, Review articles ) - Current position of vinorelbine within complex breast cancer treatment
MUDr. Silvia Jurišová, MUDr. Miroslava Malejčíková
(6/2016, Drugs & drug classes ) - Inflammatory breast cancer
doc. MUDr. Mária Wagnerová, CSc.
(2/2012, Main topic ) - Novinky zo San Antonio Breast Cancer Symposium
prof. MUDr. Stanislav Špánik, CSc., MUDr. Vladimír Malec, PhD., MUDr. Mária Rečková
(1/2013, Events ) - Správa z Best of ASCO® Slovakia 2015
MUDr. Mária Rečková
(6/2015, Events ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Chemotherapy for carcinoma of stomach
MUDr. Tomáš Šálek
(3/2011, Review articles ) - Cancer drug consumption in Slovakia and its economic impact – development and trends
prof. RNDr. Viliam Foltán, CSc., PharmDr. Veronika Dubajová, Mgr. Katarína Gatialová , Mgr. Katarína Bellová
(3/2011, Review articles ) - Ipilimumab in the treatment of malignant melanoma
MUDr. Róbert Godál
(3/2011, Drugs & drug classes ) - Správa z Best of ASCO Slovakia 2009
MUDr. Mária Rečková
(6/2009, Events ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(6/2009, Information & comments ) - Systemic treatment of breast cancer in pregnancy
MUDr. Oľga Szegheőová
(3/2016, Main topic ) - Specifics of treatment of breast cancers in women older than 70 years
doc. MUDr. Mária Wagnerová, CSc.
(5/2012, Main topic ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Financial expenditures in the context of pharmacotherapy of oncological diseases
doc. PharmDr. Tomáš Tesař, PhD., MBA, PhDr. Ľubica Hlinková, MPH
(1/2014, Main topic ) - The use of immunotherapy in pediatric oncology
MUDr. Viera Bajčiová, CSc.
(1/2014, Review articles ) - Therapeutic procedures in the treatment of advanced triple-negative breast cancer – a nationwide survey among selected oncologists from oncology institutes and regional cancer centers in Slovakia
MUDr. Radovan Barila, PhD., MUDr. Elena Marušáková, MBA, Ing. Jan Žigmond
(3/2024, Review articles ) - VI. Dni mladých onkológov vo Vyhniach
MUDr. Oľga Szegheőová
(5/2010, Events ) - Neratinib in treatment of HER2+ breast cancer – drug profile
MUDr. Radovan Barila, PhD.
(3/2020, Drugs & drug classes ) - Správy z podujatia ASCO Chicago 2014
prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková, MUDr. Patrik Palacka, PhD. MPH, MBA
(4/2014, Events ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Cardiotoxicity of drugs used in adjuvant therapy of breast cancer
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Katarína Ševčíková
(2/2009, Review articles ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - A comprehensive view of the treatment of HER2-positive breast cancer
MUDr. Bela Mriňáková, PhD., MPH
(2/2022, Main topic ) - Trastuzumab deruxtecan – drug profile and use in the treatment of advanced HER2-positive breast cancer
MUDr. Radovan Barila, PhD., MUDr. Lenka Svobodová, MUDr. Ján Bujňák, PhD.
(2/2022, Drugs & drug classes ) - Správy z podujatia ASCO Chicago 2015
(4/2015, Events ) - THE INTRODUCTION TO INTERPRETATION OF CLINICAL TRIALS – Part II.
MUDr. Michal Mego, PhD., MUDr. Mária Rečková
(3/2008, Review articles ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(3/2012, Information & comments ) - Targeted terapy of gastric cancer
MUDr. Vanda Ušáková, PhD.
(5/2014, Review articles ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Správa z Best of ASCO® Slovakia 2016
MUDr. Mária Rečková
(4/2016, Events ) - Správa z IX. bardejovských onkologických dní
doc. MUDr. Mária Wagnerová, CSc.
(4/2016, Events ) - Kam posunul trastuzumab deruxtecan liečbu HER2+ pozitívneho karcinómu prsníka?
MUDr. Miroslava Malejčíková
(2/2023, Review articles ) - Exosomes – new topic in diagnostics of cancer
RNDr. Ján Sedlák, DrSc., Mgr. Martina Zdurienčíková, RNDr. Paulína Gronesová, PhD., RNDr. Dana Cholujová, PhD., RNDr. Ľuba Hunáková, CSc.
(5/2015, Review articles ) - Efficacy and cardiotoxicity risk of adjuvant treatment in HER2-positive patients with breast cancer
MUDr. Jaroslava Lešková
(1/2020, Review articles ) - Úvodné slovo
MUDr. Radovan Barilla, PhD.
(1/2012, Editorial ) - V. BARDEJOVSKÉ ONKOLOGICKÉ DNI
doc. MUDr. Mária Wagnerová, CSc.
(6/2008, Events ) - ODPORÚČANIA SLOVENSKEJ ONKOLOGICKEJ SPOLOČNOSTI SLS PRE ANTIEMETICKÚ LIEČBU V ONKOLÓGII
Slovenská onkologická spoločnosť
(6/2008, Information & comments ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Antiemetic therapy – what has brought the last decade?
MUDr. Jana Obertová
(6/2010, Review articles ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - Pharmacological and non-pharmacological possibilities of antracycline and trastuzumab cardiotoxicity risk reduction
MUDr. Zuzana Országhová Jr., MUDr. Ľubica Harvanová, PhD., Prof. MUDr. Beata Mladosievičová, CSc.
(4/2020, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - TESTICULAR TUMOR IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS. DIFFERENCES IN BIOLOGY ACROSS THE AGE
MUDr. Viera Bajčiová, CSc.
(6/2007, Review articles ) - Treatment metastatic gastric cancer
MUDr. Vanda Ušáková, PhD.
(1/2018, Review articles ) - Metronomic chemotherapy in breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2018, Review articles ) - Niektoré nové poznatky zo sympózia ASCO GI San Francisco 2018
MUDr. Tomáš Šálek
(1/2018, Events ) - SEKCAMA 2009
MUDr. Vladimír Bella, PhD., MUDr. Dušan Malatin
(3/2009, Events ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(3/2009, Information & comments ) - Diskusné fórum onkológov
(3/2009, Discussion forum ) - NEOADJUVANT SYSTEMIC TREATMENT OF OPERABLE BREAST CANCER
prof. MUDr. Stanislav Špánik, CSc.
(3/2006, Review articles )
- Biological drugs from the perspective of pharmacy
PharmDr. Katarína Bruchatá, PhD., Mgr. Peter Heinz
(4/2014, Pharmaceutical technology ) - IX. zjazd Slovenskej farmaceutickej spoločnosti – 40. lekárnické dni
doc. RNDr. Magdaléna Fulmeková, CSc.
(2-3/2014, Events )
- Biosimilars – generic copies of various types of biotech drugs?
doc. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Pavol Hollý, PhD., MUDr. Juraj Sokol, PhD.
(1/2015, Review articles ) - The prophylaxis of venous thromboembolism and metastatic breast cancer
prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2016, Original articles & Case reports )